These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2745252)

  • 1. Desacetylcefotaxime--another broad spectrum cephalosporin?
    Fuchs PC; Jones RN; Barry AL; Allen SD; Ayers LW; Pfaller M
    J Antimicrob Chemother; 1989 Jan; 23(1):165-7. PubMed ID: 2745252
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
    Neu HC
    Rev Infect Dis; 1982; 4 Suppl():S374-8. PubMed ID: 6294786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
    Jones RN; Barry AL; Thornsberry C
    Rev Infect Dis; 1982; 4 Suppl():S366-73. PubMed ID: 6294785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
    Jones RN; Barry AL
    Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime.
    Fuchs PC; Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(1):81-5. PubMed ID: 2714075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of cefotaxime, desacetylcefotaxime, and the combination of the two.
    Friis H
    Diagn Microbiol Infect Dis; 1989; 12(1):67-72. PubMed ID: 2714074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
    Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of the activity of cefotaxime and desacetylated cefotaxime and of their combination.
    Nanetti A; La Placa M
    J Chemother; 1990 Jun; 2(3):159-63. PubMed ID: 2380765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime.
    Molinari G; Saverino D; Paglia P; Debbia EA; Schito GC
    J Chemother; 1991 Feb; 3(1):6-12. PubMed ID: 2019866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symposium: new findings on the antibacterial interactions between cefotaxime and desacetylcefotaxime.
    Diagn Microbiol Infect Dis; 1989; 12(1):23-121. PubMed ID: 2714069
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
    Oizumi K; Hayashi I; Aonuma S; Konno K
    Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
    Bremner DA
    Chemotherapy; 1983; 29(4):283-8. PubMed ID: 6307605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of cefotaxime and desacetylcefotaxime, alone or in combination, against gram-positive cocci.
    Cruciani M; Navarra A; Di Perri G; Danzi MC; Concia E; Bassetti D
    Drugs Exp Clin Res; 1990; 16(11):565-8. PubMed ID: 2101779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotaxime stability during in vitro microbiological testing.
    Marchbanks CR; Yost RL; White RL
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1375-8. PubMed ID: 3314698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
    Aldridge KE; Sanders CV; Marier RL
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.
    Piédrola G; Galan I; Leyva A; Maroto MC
    Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro evaluation of the activity and interactions of cefotaxime and its metabolite desacetylcefotaxime against strains of enterobacteria, staphylococci and Bacteroides fragilis isolated from hospital infections].
    Pitzus E
    G Ital Chemioter; 1989; 36(1-3):57-64. PubMed ID: 2488914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test.
    Reller LB
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
    Schrinner E; Limbert M; Seeger K; Seibert G; Novick WJ
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria.
    Devlin HR; Boskovski L
    Drugs; 1988; 35 Suppl 2():45-50. PubMed ID: 3396488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.